T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 26 (2) , 123-129
- https://doi.org/10.1016/0198-8859(89)90097-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- CHARACTERIZATION OF PERIPHERAL BLOOD CD8/11 CELLS IN BONE MARROW TRANSPLANT RECIPIENTSTransplantation, 1988
- Experience with OKT3 in Vascularized Pancreas TransplantationPublished by Elsevier ,1988
- OKT3 Monoclonal Antibody in Heart TransplantationAmerican Journal of Kidney Diseases, 1988
- Immunologic Monitoring During and After OKT3 TherapyAmerican Journal of Kidney Diseases, 1988
- Complications and Monitoring of OKT3 TherapyAmerican Journal of Kidney Diseases, 1988
- Early Use of OKT3 Monoclonal Antibody in Renal Transplantation to Prevent RejectionAmerican Journal of Kidney Diseases, 1988
- OKT3 TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTIONTransplantation, 1987
- PROPHYLACTIC USE OF OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY RECIPIENTS UTILIZATION OF OKT3 AS THE SOLE IMMUNOSUPPRESSIVE AGENTTransplantation, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Monoclonal Antibodies Defining Distinctive Human T Cell Surface AntigensScience, 1979